Evidence map›Paper›PMID 30745229›Full record

ArticleAtherosclerosis2019

Heparanase in health and disease: The neglected housekeeper of the cell?

Jun Shu, Gaetano Santulli

Abstract readEditorial
In one paragraph

Article in Atherosclerosis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jun ShuDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, USA.
Gaetano SantulliDepartment of Medicine and Department of Molecular Pharmacology, The Wilf Family Cardiovascular Research Institute, New York, NY, USA; "The Norman Fleischer Institute for Diabetes and Metabolism", Einstein-Sinai Diabetes Research Center, Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY, USA; Department of Biomedical Advanced Sciences, "Federico II" University, Naples, Italy. Electronic address: GSantulli001@Gmail.com.

Funding

Functional role of IP3 receptors in the regulation of cardiac myofibroblastsR01HL146691 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SANTULLI, GAETANO · 2019 to 2023
$2.1M
Targeting intracellular calcium leak as novel therapy for diabetesR00DK107895 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SANTULLI, GAETANO · 2018 to 2020
$741k
Targeting intracellular calcium leak as novel therapy for diabetesK99DK107895 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SANTULLI, GAETANO · 2015 to 2016
$176k
NHLBI NIH HHS R01 HL146691NIDDK NIH HHS K99 DK107895NIDDK NIH HHS R00 DK107895
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAtherosclerosisDisease ProgressionExtracellular MatrixGlucuronidaseHeparanaseHumansMuscle, Smooth, VascularGlucuronidaseHeparanaseGlycocalyxHeparanaseHeparan-sulfateProteoglycan

Identifiers

PMID30745229
PMCPMC6755666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.